[Effect analysis on non-and-low response infants after revaccinated hepatitis B vaccine]

Zhen-hua Wu1, Fu-qiang Cui, Xiao-hong Gong

  • 1Union School of Public Health of Peking Union Medical College, Beijing 102200, China.

Zhongguo Yi Miao He Mian Yi
|August 24, 2010
PubMed

Insights

Booster immunizations significantly improve Hepatitis B (HepB) antibody titers in non- and low-response children. A three-dose booster regimen is more effective than a single dose for achieving high protective antibody levels.

Area of Science:

  • Immunology
  • Vaccinology
  • Pediatrics

Context:

  • Hepatitis B (HepB) vaccination is crucial for preventing infection.
  • Some children exhibit non- or low-response after initial HepB immunization.
  • Booster doses are explored to enhance immunity in these individuals.

Purpose:

  • To assess the effectiveness of booster immunizations in children with non- and low-response to primary HepB vaccination.
  • To compare the serological outcomes of single-dose versus three-dose HepB booster regimens.
  • To evaluate different formulations of HepB vaccines for booster efficacy.

Summary:

  • A study involving non- and low-response infants demonstrated that a three-dose Hepatitis B (HepB) booster regimen significantly increased geometric mean concentrations (GMC) and the proportion of children with high antibody titers compared to a single dose.
  • All tested HepB vaccine formulations (5 mcg HepB-Y, 10 mcg HepB-Y, 10 mcg HepB-CHO, 10 mcg HepB-HY) showed similar immunogenic effects after a three-dose booster schedule.
  • While seroconversion rates were comparable between one and three doses, the three-dose booster resulted in significantly higher antibody titers.

Impact:

  • Provides evidence supporting the use of a three-dose booster strategy to improve protective immunity against Hepatitis B in non- and low-responders.
  • Suggests that multiple HepB vaccine formulations can be effectively used for booster immunizations.
  • Contributes to optimizing vaccination schedules for vulnerable pediatric populations.
Abstract